|
|
||||||||
1Program in Fetal Medicine, Departments of 2Pathology and 4Pediatrics, Women and Infants Hospital, Providence 02905; and Departments of 3Pathology and Laboratory Medicine, 5Pediatrics, and 6Surgery, Brown Medical School, Providence, Rhode Island 02905
Submitted 1 April 2004 ; accepted in final form 19 May 2004
Postcanalicular lung development is characterized by a time-specific increase in alveolar epithelial type II cell apoptosis. We have previously demonstrated that, in fetal rabbits, developmental type II cell apoptosis coincides with transient upregulation of the cell death regulator Fas ligand (FasL). The aims of this study were 1) to determine the spatiotemporal patterns of pulmonary apoptosis and Fas/FasL gene expression in the murine model [embryonic day 17 (E17) through postnatal day 5 (P5)], and 2) to investigate the functional involvement of the Fas/FasL system by determining the effect of Fas activation and inhibition on perinatal pulmonary apoptosis. The apoptotic activity of alveolar epithelial type II cells, determined by combined TUNEL labeling and anti-surfactant protein B immunohistochemistry, showed a dramatic increase during the perinatal transition (type II cell apoptotic index <0.1% at E17, 1.5% at P1-P3, and 0.3% at P5). This timing of enhanced type II cell apoptosis coincided with a robust 14-fold increase in Fas mRNA and protein levels and a threefold increase in FasL protein levels; both Fas and FasL immunolocalized to type II and bronchial epithelial cells. In vitro and in vivo exposure of fetal and postnatal murine type II cells to anti-Fas antibody induced a fourfold increase in apoptotic activity that was prevented by administration of a broad-spectrum caspase inhibitor; the pulmonary apoptotic activity of Fas-deficient lpr mice remained unchanged. Conversely, administration of a caspase inhibitor to newborn mice (P1) resulted in marked diminution of pulmonary apoptotic activity. These combined findings strongly implicate the Fas/FasL system as a critical regulator of perinatal type II cell apoptosis. The developmental time dependence of apoptosis-related events in the murine model should facilitate investigations of the regulation of perinatal pulmonary apoptotic gene expression.
programmed cell death; lpr; CD95; lung development
This article has been cited by other articles:
![]() |
M. E. De Paepe, C. Patel, A. Tsai, S. Gundavarapu, and Q. Mao Endoglin (CD105) Up-regulation in Pulmonary Microvasculature of Ventilated Preterm Infants Am. J. Respir. Crit. Care Med., July 15, 2008; 178(2): 180 - 187. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yi, R. Belcastro, S. Shek, D. Luo, M. Post, and A. K. Tanswell Fibroblast Growth Factor-2 and Receptor-1{alpha}(IIIc) Regulate Postnatal Rat Lung Cell Apoptosis Am. J. Respir. Crit. Care Med., September 1, 2006; 174(5): 581 - 589. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, R. Pop, C. Sadegh, C. Brugnara, V. H. Haase, and M. Socolovsky Suppression of Fas-FasL coexpression by erythropoietin mediates erythroblast expansion during the erythropoietic stress response in vivo Blood, July 1, 2006; 108(1): 123 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. De Paepe, Q. Mao, J. Powell, S. E. Rubin, P. DeKoninck, N. Appel, M. Dixon, and F. Gundogan Growth of Pulmonary Microvasculature in Ventilated Preterm Infants Am. J. Respir. Crit. Care Med., January 15, 2006; 173(2): 204 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. De Paepe, Q. Mao, Y. Chao, J. L. Powell, L. P. Rubin, and S. Sharma Hyperoxia-induced apoptosis and Fas/FasL expression in lung epithelial cells Am J Physiol Lung Cell Mol Physiol, October 1, 2005; 289(4): L647 - L659. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wang and M. You Five Loci, SLT1 to SLT5, Controlling the Susceptibility to Spontaneously Occurring Lung Cancer in Mice Cancer Res., September 15, 2005; 65(18): 8158 - 8165. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |